Neumirna at the EVF global accelerator course

$250,000 in funding to support biomarker research and development of RNA therapy for drug-resistant epilepsy

$200,000 award supports Neumirna’s RNA-based approach to innovation in epilepsy treatment

This grant from the Innovation Fund Denmark (IFD) will help us in further establishing our drug discovery pipeline, aimed at developing disease-modifying RNA Therapies for Parkinson's Disease at NEUmiRNA, in collaboration with Aalborg University and the Center for RNA Medicine (CRM).